Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy

Recruiting N/A Interventional Study
Coronary Artery Disease Myocardial Ischaemia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,066 (estimated)
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years, with at least one vessel has CT-derived FFR≤0.80 * Patients with chronic coronary syndromes * Signed written informed consent Exclusion Criteria: * The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspi…
Contacts

Jian'an Wang, MD

+(86)(571) 87784808

wangjianan111@zju.edu.cn

CONTACT